A1C estimates your average blood sugar over about the past 2 to 3 months. In general, below 5.7% is considered normal, 5.7% to 6.4% is in the prediabetes range, and 6.5% or higher can support a diabetes diagnosis when confirmed by a clinician. Your personal target may differ.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →| A1C | Estimated average glucose, eAG | Common interpretation |
|---|---|---|
| 5.0% | About 97 mg/dL | Often in the normal range |
| 5.7% | About 117 mg/dL | Lower end of the prediabetes range |
| 6.0% | About 126 mg/dL | Prediabetes range |
| 6.5% | About 140 mg/dL | Diabetes-range if confirmed by a clinician |
| 7.0% | About 154 mg/dL | Common treatment goal reference for many adults with diabetes, but individualized |
| 8.0% | About 183 mg/dL | Above goal for many adults with diabetes |
| 9.0% | About 212 mg/dL | High average glucose over time |
| 10.0% | About 240 mg/dL | Very high average glucose over time |
| 12.0% | About 298 mg/dL | Very high average glucose over time |
What does an A1C chart show about average blood sugar?
An A1C chart shows how a lab A1C percentage lines up with an estimated average glucose number in mg/dL. That estimate is useful because many people are used to seeing glucose numbers on a meter or continuous glucose monitor, not percentages.
Quick facts: A1C, estimated average glucose, and what the numbers can and cannot tell you
- Hemoglobin A1C, HbA1c, and glycated hemoglobin mean the same basic test: how much glucose is attached to hemoglobin in red blood cells 1.
- Estimated average glucose, or eAG, is a translation of A1C into mg/dL, based on the ADAG study relationship 3.
- A1C gives a longer-term view than fasting blood glucose, post-meal blood glucose, a blood glucose meter, or a CGM reading 1.
- A1C cannot show daily swings, overnight lows, or post-meal spikes by itself.
A1C percentage vs estimated average glucose in mg/dL
The eAG formula most often used is: eAG in mg/dL = 28.7 × A1C − 46.7. This came from the ADAG study, which compared A1C with many glucose measurements over time 3.
Why A1C is an average, not a real-time blood sugar reading
A1C is shaped by glucose exposure across the life of red blood cells, which is why it reflects roughly the past few months rather than this morning’s glucose 1. A person can have the same A1C as someone else but very different daily patterns, including more highs after meals or more lows overnight.
If you are comparing A1C with home readings, it can help to review a normal blood sugar levels chart and talk with your clinician about whether fasting, after-meal, or overnight values are driving the result.
What A1C ranges are considered normal, prediabetes, or diabetes?
The common reference ranges are below 5.7%, 5.7% to 6.4%, and 6.5% or higher. These ranges are screening and diagnostic guideposts, not a full diagnosis by themselves 2.
| A1C range | Common category | What it usually means |
|---|---|---|
| Below 5.7% | Normal range | Average glucose is not in the prediabetes or diabetes range 2. |
| 5.7% to 6.4% | Prediabetes range | Glucose is higher than normal, and future type 2 diabetes risk is higher 2, 4. |
| 6.5% or higher | Diabetes-range | Can support a diabetes diagnosis when confirmed and interpreted by a clinician 5. |
Normal A1C range
An A1C below 5.7% is commonly considered normal 2. If your result is normal but you have symptoms, risk factors, or a strong family history, your clinician may still check fasting blood glucose, after-meal glucose, or other labs.
Prediabetes A1C range
An A1C of 5.7% to 6.4% is commonly considered prediabetes 2. In a systematic review, higher A1C values in this range were linked with higher future diabetes risk, especially around 6.0% to 6.5% 4.
Prediabetes is not a personal failure. It is a signal to look at insulin resistance, weight, activity, sleep, medications, and family risk. Our guide to whether prediabetes can be reversed explains what changes have the strongest evidence.
Diabetes-range A1C and why confirmation matters
An A1C of 6.5% or higher is in the diabetes range, but a clinician should confirm the result and interpret it with symptoms, repeat testing, or other glucose tests 5. This matters because lab error, red blood cell conditions, pregnancy, and kidney disease can change how reliable A1C is.
When finger-prick or vein-draw A1C results may differ
A1C can be checked from a finger-prick sample or from blood drawn from a vein. Vein-draw lab testing is generally more accurate, while point-of-care tests can be useful for quick checks in a clinic 2.
What is a good A1C by age?
There is no single good A1C for every age. For many nonpregnant adults with diabetes, an A1C goal around 7% or lower is often referenced, but safer targets may be lower or higher depending on health, medications, and hypoglycemia risk 5.
Why adults do not all have the same A1C target
A younger adult with few medical problems may have a different target than someone with heart disease, kidney disease, memory changes, or frequent low blood sugar. The goal is not just a lower number; it is a safer pattern of glucose over time 5.
Why older adults, pregnancy, hypoglycemia risk, and other conditions can change targets
Older adults, pregnant patients, and people at high risk for hypoglycemia often need more individualized goals. Pregnancy changes glucose goals and medication choices, and diabetes treatment in pregnancy has been studied as a distinct clinical situation 6.
Why children and teens need individualized goals from a diabetes care team
Children and teens with type 1 diabetes need goals set by a pediatric diabetes team because growth, school schedules, activity, puberty, insulin use, and hypoglycemia risk all matter. Studies in children with type 1 diabetes show that diabetes technology, including CGM, is often evaluated alongside A1C rather than replacing clinical judgment 7.
What raises A1C the most?
A1C rises when glucose is often above target over time. The biggest drivers are usually frequent post-meal highs, insulin resistance, missed or insufficient medication, illness, poor sleep, stress, weight gain, and medications that raise glucose 5.
Frequent high blood sugar after meals
Post-meal blood glucose can strongly affect A1C, especially when it happens often. A person can have a normal fasting glucose but still have high after-meal readings that push A1C upward, which is one reason A1C and finger-stick readings may not seem to match 5.
Insulin resistance, weight gain, sleep, stress, illness, and medications
Insulin resistance means the body has a harder time moving glucose from the blood into cells. It is closely linked with excess visceral fat, inactivity, sleep loss, some medications, and type 2 diabetes risk 5. If this is your concern, start with our plain-language guide to what insulin resistance is.
Care-team support can also matter. In an outpatient diabetes study, pharmacist intervention was evaluated as a way to reduce re-elevation of glycated hemoglobin, showing how follow-up and medication support can be part of A1C care 8.
Why A1C can be misleading in anemia, kidney disease, pregnancy, or altered red blood cell turnover
A1C depends on red blood cells and hemoglobin glycation. Anything that changes red blood cell lifespan or hemoglobin can make A1C less reliable, including some anemias, kidney disease, pregnancy, recent blood loss, transfusion, or certain hemoglobin variants 5.
Is there a “stroke level” A1C?
No. A1C is not an emergency stroke test and does not diagnose a stroke. Stroke symptoms are urgent no matter what your A1C is.
Why A1C is not an emergency stroke test
A1C reflects average glucose over weeks to months, not what is happening in the brain or blood vessels right now 1. Emergency teams use symptoms, exam findings, imaging, and real-time labs to evaluate stroke-like symptoms.
When high blood sugar or stroke-like symptoms need urgent care
Call emergency services for face drooping, arm weakness, speech trouble, sudden confusion, sudden vision changes, severe headache, fainting, or one-sided numbness. Also seek urgent care for severe hyperglycemia symptoms, repeated vomiting, dehydration, confusion, or severe hypoglycemia symptoms 11, 12.
How long-term high A1C relates to future diabetes and complication risk
While A1C is not a stroke alarm, long-term high glucose is part of cardiometabolic risk. A systematic review found that higher A1C in the prediabetes range was associated with higher future diabetes risk 4.
How can someone lower A1C safely?
The safest plan depends on why A1C is high. For many people, the strongest starting points are food quality, activity, weight loss when appropriate, sleep, medication adherence, and better glucose pattern tracking 5.
Food changes with the strongest practical impact
Food changes that often help include replacing sugary drinks, adding protein and fiber to meals, choosing less-processed carbohydrates, and watching portions of refined starches 5. If you are building meals around glucose control, our healthy diet for insulin resistance guide gives a practical starting point.
Physical activity, weight loss, sleep, and medication adherence
Physical activity helps muscles use glucose, and weight loss can improve insulin resistance for some people 5. Even modest weight loss has been studied as part of diabetes prevention and prediabetes care; our article on weight loss for prediabetes explains the evidence and limits.
When home glucose meters or continuous glucose monitors can add useful context
A blood glucose meter or continuous glucose monitor can show patterns A1C cannot, such as post-meal spikes or overnight lows 5. In children with type 1 diabetes, researchers have evaluated A1C before and after CGM initiation, showing how CGM can add pattern data beyond the A1C number 7.
3-min quiz
Considering weight-loss care as part of an insulin-resistance plan?
If excess weight is part of your A1C or insulin-resistance picture, Chia can help you explore clinician-reviewed options. A licensed US provider reviews your health history and prescribes only when clinically appropriate; a prescription is never guaranteed. Chia’s compounded medications are made by state-licensed 503A pharmacies and are not FDA-approved. You can learn about compounded semaglutide injection, tirzepatide tablets or injection, or Weight + Energy.
When weight-loss treatment at Chia may fit into an A1C plan
Weight-loss treatment may fit when excess weight, insulin resistance, or prediabetes is part of the clinical picture. At Chia, this starts with a 100% online health questionnaire and a licensed-provider review, not an automatic prescription.
When excess weight, insulin resistance, or prediabetes may prompt a clinician-reviewed weight-loss plan
For some people, reducing body weight can improve insulin resistance and support healthier glucose patterns. Treatment choice depends on eligibility, medical history, current medications, pregnancy status, kidney or gallbladder history, pancreatitis history, and clinician evaluation.
Semaglutide at Chia: compounded semaglutide injection through a licensed provider when appropriate
Semaglutide is the active ingredient in Ozempic and Wegovy and is a GLP-1 receptor agonist; Chia offers compounded semaglutide via a 503A pharmacy as an injection, with microdosing plans available when appropriate. Plans currently start at $249/mo, and dosing is provider-guided and adjusted over time.
In FDA-approved labeling for semaglutide products, the active ingredient is associated with weight and glucose effects, but compounded semaglutide formulations are not FDA-approved and do not have FDA-evaluated outcomes data 9. Common side effects can include nausea, vomiting, diarrhea, constipation, and abdominal pain; labeled warnings include risks such as pancreatitis, gallbladder disease, kidney injury from dehydration, and contraindication in people with a personal or family history of medullary thyroid carcinoma or MEN2 9.
Tirzepatide at Chia: tablets or injections, including microdosing plans when appropriate
Tirzepatide is the active ingredient in Mounjaro and Zepbound and is a dual GIP/GLP-1 receptor agonist; Chia offers compounded tirzepatide via a 503A pharmacy as tablets or injection, with microdosing plans available when appropriate. Tablet plans currently start at $249/mo, and injection plans currently start at $299/mo.
In FDA-approved labeling for tirzepatide products, the active ingredient is associated with weight and glucose effects, but compounded tirzepatide formulations are not FDA-approved and do not have FDA-evaluated outcomes data 10. Common side effects can include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion; labeled warnings include pancreatitis, gallbladder disease, kidney injury from dehydration, severe gastrointestinal disease cautions, and contraindication in people with a personal or family history of medullary thyroid carcinoma or MEN2 10.
| Chia option | Forms listed in Chia catalog | Current starting price | How it may fit |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | May fit eligible patients seeking provider-guided GLP-1 weight-loss care. |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injection from $299/mo | May fit eligible patients seeking provider-guided dual GIP/GLP-1 weight-loss care. |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/mo | May fit eligible patients whose plan includes weight-loss care plus NAD+ injection. |
What Chia does not do: no guaranteed prescription and no replacement for diabetes care
Chia’s GLP-1 care is not a replacement for diabetes diagnosis, emergency care, or ongoing diabetes management with your primary care clinician or endocrinologist. We prescribe only when clinically appropriate after a licensed-provider evaluation, and patients can message their care team through the patient portal between visits.
What should you ask your clinician after an A1C result?
The best next question depends on the result. Ask what the number means for you, whether it should be repeated, and which daily glucose patterns or health risks matter most.
Questions to ask if your A1C is normal
- Do I need repeat testing based on my risk factors?
- Should I also check fasting blood glucose or lipids?
- Are my weight, waist size, blood pressure, or family history raising my future risk?
Questions to ask if your A1C is in the prediabetes range
- Should we repeat the A1C or check fasting glucose?
- What is most likely driving this: insulin resistance, weight, medications, sleep, or another condition?
- Would a structured nutrition, activity, or weight-loss plan be appropriate?
- How often should I recheck A1C?
Questions to ask if your A1C is in the diabetes range
- How will we confirm the diagnosis?
- Should I check home glucose now, and when?
- Do I need diabetes medication, nutrition support, or a diabetes educator?
- What symptoms should make me seek urgent care?
- What A1C target is safe for me?
3-min quiz
Start with a clinician-reviewed plan
If your A1C has you thinking about insulin resistance, weight, and next steps, Chia can help you explore whether online weight-loss care is appropriate. The visit is reviewed by a licensed provider, treatment is prescribed only when clinically appropriate, and medications are shipped to your door from state-licensed 503A pharmacies.
FAQ: Average blood sugar and A1C chart
Yes. A1C can be higher if blood sugar often rises after meals, even when fasting glucose looks normal. A meter or CGM may help show those patterns 5.
It can start to change within a month, but A1C reflects about 2 to 3 months of glucose exposure 1. Your clinician may time repeat testing based on your result and treatment plan.
Usually, no. A1C does not require fasting because it reflects average blood sugar over time, not your glucose at that moment 2.
For some eligible patients, weight-loss treatment can be part of a broader plan for insulin resistance or abnormal glucose. The choice depends on diagnosis, medical history, current medications, side effect risk, and clinician evaluation. Compounded GLP-1 medications are not FDA-approved and do not have FDA-evaluated outcomes data.
References
- 1.American Diabetes Association. Understanding A1C. American Diabetes Association, 2026.
- 2.Cleveland Clinic. A1C: What It Is, Test, Levels & Chart. Cleveland Clinic, 2025.
- 3.Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C Assay Into Estimated Average Glucose Values. Diabetes Care. 2008.
- 4.Zhang X, Gregg EW, Williamson DF, Barker LE, Thomas W, Bullard KM, Imperatore G, Williams DE, Albright AL. A1C Level and Future Risk of Diabetes: A Systematic Review. Diabetes Care. 2010.
- 5.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care. 2026.
- 6.Smith JG, Manuck TA, White J, et al. Insulin glargine versus neutral protamine Hagedorn insulin for treatment of diabetes in pregnancy. American Journal of Perinatology. 2009.
- 7.Gurnurkar S, Owens L, Chalise S, et al. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism. 2021.
- 8.Maiguma T, Komoto A, Shiraga E, et al. Influence of Pharmacist Intervention on Re-Elevation of Glycated Hemoglobin for Diabetic Outpatients. Hospital Pharmacy. 2021.
- 9.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
- 10.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2025.
- 11.Centers for Disease Control and Prevention. Signs and Symptoms of Stroke. CDC, 2024.
- 12.American Diabetes Association. Hypoglycemia (Low Blood Glucose) and Hyperglycemia (High Blood Glucose). American Diabetes Association, 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



